PAREXEL

Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.

Jenny Denney, EVP, Head of FSP Clinical and Biometrics at Parexel, discusses current transformations in the industry in addition to how Parexel, as the landscape shifts, supports clients with proper models and infrastructure from a functional service provider (FSP) perspective.

Webinar Date/Time: Mon, Dec 4, 2023 11:00 AM EST

By employing effective use of the patient voice, companies can better boost patient engagement success.

In these videos, Matthew Gordon from Parexel International explores the challenges and benefits that go hand in hand with implementing real-world evidence (RWE) innovations.

There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.

Webinar Date/Time: Thu, Jul 20, 2023 11:00am EDT | 4pm BST | 5pm CEST

Webinar Date/Time: Wed, May 10, 2023 11:00 AM EDT

Available On Demand The use of real-world data in clinical research is on the rise – but what are the logistics of tokenizing and linking RCT data? Parexel and Datavant discuss how to implement tokenization within a clinical trial in an informative webinar. Tune in to learn more!

Tuesday, April 12, 2022 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST ** Tuesday, April 19, 2022 at 8:30am CST | 5:30pm PDT | 8:30PM EDT This webinar will include an educational session with Parexel experts, who will address how to build an evidence strategy for your cancer drug that is both approvable and reimbursable.

This video series discusses the impact of implementing risk-based quality management (RBQM) and decentralized clinical trials (DCTs) from the clinical operations point of view.

Available On Demand This panel discussion will include an informative conversation among Parexel experts, who will share key considerations in accelerating drug development for rare diseases.

Europe & US: Wednesday, September 22, 2021 at 1:30pm BST | 8:30am EDT Asia & US: Tuesday, September 28, 2021 at 7:30am CST | 4:30pm PDT This panel discussion will include a lively conversation with Parexel regulatory experts from USA, Europe, and China, who will address how to utilize simultaneous expedited approvals to accelerate global drug development.